BioCentury | Feb 29, 2016
Product Development

Oncolytic duos and Dx

...OBP-401 ) is an adenovirus encoding the human telomerase reverse transcriptase (hTERT) promoter and GFP. TelomeScan...
...TelomeScan in North America. Chairman, President and CEO Philip Sass said the company has studied TelomeScan...
BioCentury | Mar 18, 2013
Company News

Geron, Oncolys BioPharma deal

...with its TelomeScan to detect circulating tumor cells (CTCs) in the blood of cancer patients. TelomeScan...
BioCentury | Sep 10, 2009
Distillery Techniques

Technology: Imaging

...and contact information Imaging Replication-competent adenovirus expressing green fluorescent protein to detect circulating tumor cells OBP-401...
...In peripheral blood samples from 37 gastric cancer patients and 9 patients with other malignancies, OBP-401...
...in cancer patients to confirm that the approach is useful for monitoring disease status. TelomeScan (OBP-401...
BioCentury | Sep 3, 2009
Distillery Techniques

Technology: Imaging

...and contact information Imaging Telomerase-dependent, replication-competent adenovirus expressing green fluorescent protein to guide tumor resection OBP-401...
...surgical resection of tumor tissue. In mice with disseminated human lung cancer tumors, injection of OBP-401...
...Next steps include evaluating the safety and efficacy of OBP-401 in additional animal models. TelomeScan (OBP-401...
BioCentury | Aug 24, 2009
Clinical News

AntiCancer, Oncolys Biopharma preclinical data

...cancer, OBP-401 labeled all cancer present and fluoresced under a simple lighting and filter apparatus. OBP-401...
...adenovirus. AntiCancer Inc. , San Diego, Calif. Oncolys Biopharma , Tokyo, Japan Product: Telomescan ( OBP-401...
Items per page:
1 - 5 of 5